These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


950 related items for PubMed ID: 27233938

  • 1. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.
    Tabet R, Moutin E, Becker JA, Heintz D, Fouillen L, Flatter E, Krężel W, Alunni V, Koebel P, Dembélé D, Tassone F, Bardoni B, Mandel JL, Vitale N, Muller D, Le Merrer J, Moine H.
    Proc Natl Acad Sci U S A; 2016 Jun 28; 113(26):E3619-28. PubMed ID: 27233938
    [Abstract] [Full Text] [Related]

  • 2. Fragile X syndrome: Are signaling lipids the missing culprits?
    Tabet R, Vitale N, Moine H.
    Biochimie; 2016 Nov 28; 130():188-194. PubMed ID: 27597551
    [Abstract] [Full Text] [Related]

  • 3. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K, Chen H, Gennarino VA, Richman R, Lu HC, Zoghbi HY.
    Hum Mol Genet; 2015 Apr 01; 24(7):1813-23. PubMed ID: 25432536
    [Abstract] [Full Text] [Related]

  • 4. Fragile X Mental Retardation Protein and Dendritic Local Translation of the Alpha Subunit of the Calcium/Calmodulin-Dependent Kinase II Messenger RNA Are Required for the Structural Plasticity Underlying Olfactory Learning.
    Daroles L, Gribaudo S, Doulazmi M, Scotto-Lomassese S, Dubacq C, Mandairon N, Greer CA, Didier A, Trembleau A, Caillé I.
    Biol Psychiatry; 2016 Jul 15; 80(2):149-159. PubMed ID: 26372002
    [Abstract] [Full Text] [Related]

  • 5. AAV-delivered diacylglycerol kinase DGKk achieves long-term rescue of fragile X syndrome mouse model.
    Habbas K, Cakil O, Zámbó B, Tabet R, Riet F, Dembele D, Mandel JL, Hocquemiller M, Laufer R, Piguet F, Moine H.
    EMBO Mol Med; 2022 May 09; 14(5):e14649. PubMed ID: 35373916
    [Abstract] [Full Text] [Related]

  • 6. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
    Gray EE, Murphy JG, Liu Y, Trang I, Tabor GT, Lin L, Hoffman DA.
    J Neurosci; 2019 Sep 18; 39(38):7453-7464. PubMed ID: 31350260
    [Abstract] [Full Text] [Related]

  • 7. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP, Wang YY, Liu D, Lei HY, Yang ZH, Zhang ZW, Han M, Cheng K, Chen YS, Li JQ, Cheng GR, Xu L, Wu QM, McClintock SM, Yang Y, Zhang Y, Zeng Y.
    J Neurosci; 2020 Feb 05; 40(6):1355-1365. PubMed ID: 31882402
    [Abstract] [Full Text] [Related]

  • 8. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities.
    Schütt J, Falley K, Richter D, Kreienkamp HJ, Kindler S.
    J Biol Chem; 2009 Sep 18; 284(38):25479-87. PubMed ID: 19640847
    [Abstract] [Full Text] [Related]

  • 9. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
    Muddashetty RS, Kelić S, Gross C, Xu M, Bassell GJ.
    J Neurosci; 2007 May 16; 27(20):5338-48. PubMed ID: 17507556
    [Abstract] [Full Text] [Related]

  • 10. Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome.
    Deng PY, Klyachko VA.
    J Physiol; 2016 Jan 01; 594(1):83-97. PubMed ID: 26427907
    [Abstract] [Full Text] [Related]

  • 11. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H, Schin CS, Chiang MS, Morel L, Shoneye TA, Nelson DL, Yang Y.
    J Neurosci; 2016 Jul 06; 36(27):7079-94. PubMed ID: 27383586
    [Abstract] [Full Text] [Related]

  • 12. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
    Iliff AJ, Renoux AJ, Krans A, Usdin K, Sutton MA, Todd PK.
    Hum Mol Genet; 2013 Mar 15; 22(6):1180-92. PubMed ID: 23250915
    [Abstract] [Full Text] [Related]

  • 13. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
    Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, Bassell GJ, Warren ST.
    J Biol Chem; 2008 Jul 04; 283(27):18478-82. PubMed ID: 18474609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BDNF in fragile X syndrome.
    Castrén ML, Castrén E.
    Neuropharmacology; 2014 Jan 04; 76 Pt C():729-36. PubMed ID: 23727436
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses.
    Antar LN, Li C, Zhang H, Carroll RC, Bassell GJ.
    Mol Cell Neurosci; 2006 Jan 04; 32(1-2):37-48. PubMed ID: 16631377
    [Abstract] [Full Text] [Related]

  • 19. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC, Lin Z, de Gruiter HM, van 't Spijker H, Haasdijk ED, Cox D, Ozcan S, van Cappellen GWA, Houtsmuller AB, Willemsen R, de Zeeuw CI, Bahn S.
    Mol Autism; 2016 Jan 04; 7():17. PubMed ID: 26933487
    [Abstract] [Full Text] [Related]

  • 20. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
    Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST, Bassell GJ.
    J Neurosci; 2010 Aug 11; 30(32):10624-38. PubMed ID: 20702695
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.